Case study demonstrated resolution of lytic lesions, significant reduction in pain and prevention of fracture. ZetaMet™ is a first-of-its kind molecular pathway designed to suspend cancer, inhibit ...

The American Society for Radiation Oncology has issued an updated clinical guideline that outlines best practices for addressing symptomatic bone metastases and improving quality of life for these ...

Aerobic and resistance exercise can significantly improve physical performance in patients living with metastatic breast ...

Bone metastases represent a formidable complication in advanced cancer, often resulting in severe pain, skeletal instability and a diminished quality of life. In recent years, significant progress has ...

Zetagen Therapeutics, a privately held clinical-stage biopharmaceutical company pioneering first-of-its-kind targeted therapies for both primary and metastatic breast cancer, announced today that its ...

BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for patients with bone metastases from breast cancer, and also appeared to be ...

AUGUST 7, 2025, NEW YORK – Many major cancers, including those of the lung, breast and prostate gland, spread to the bones as they progress. These bone metastases are often debilitating, even deadly.

Bone is a common site for metastasis of solid cancers, but histological and molecular features of bone metastases are not well understood. In a new study published in Cell Genomics, researchers at ...

Flash ultra-high dose rate therapy enabled by Varian proton and planning technologies Collaboration between Varian and leading institutions drives progress toward next-generation cancer treatments ...